|
Insider Trading: METABASIS THERAPEUTICS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of METABASIS THERAPEUTICS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of METABASIS THERAPEUTICS INC since year 2005. Table 2 shows the detailed insider transactions of METABASIS THERAPEUTICS INC since 2005.
The reporting company's ticker symbol is MBRX.
The reporting company's CIK number is 1053221.
The total value of stock buying since 2005 is $24,855,618.
The total value of stock sales is $428,418.
The total value of stock exercises is $22,027.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at METABASIS THERAPEUTICS INC (MBRX) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at METABASIS THERAPEUTICS INC (MBRX) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for METABASIS THERAPEUTICS INC (MBRX).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-04 | 2,331,997 | 5,456,871 | 0 | 0 | 0 | 0 |
| 2007-06 | 0 | 0 | 13,435 | 107,706 | 0 | 0 |
| 2007-05 | 0 | 0 | 300 | 2,400 | 0 | 0 |
| 2007-04 | 0 | 0 | 15,600 | 126,132 | 0 | 0 |
| 2007-02 | 0 | 0 | 4,000 | 32,000 | 0 | 0 |
| 2006-12 | 0 | 0 | 9,000 | 72,000 | 0 | 0 |
| 2006-11 | 527,000 | 3,776,323 | 9,500 | 76,005 | 0 | 0 |
| 2006-06 | 0 | 0 | 500 | 4,175 | 11,864 | 22,027 |
| 2006-05 | 50,000 | 401,524 | 0 | 0 | 0 | 0 |
| 2006-03 | 0 | 0 | 1,000 | 8,000 | 0 | 0 |
| 2005-09 | 2,598,857 | 15,220,900 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for METABASIS THERAPEUTICS INC (MBRX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-04-16 | Rosch Thomas L (10% Owner) | Purchase | 990,816 | 2.34 | 2,318,509 |
| 2008-04-16 | Galakatos Nicholas (10% Owner) | Purchase | 71,866 | 2.34 | 168,166 |
| 2008-04-16 | Oronsky Arnold L (Director) | Purchase | 990,816 | 2.34 | 2,318,509 |
| 2008-04-16 | Evnin Luke (Director) | Purchase | 71,866 | 2.34 | 168,166 |
| 2008-04-16 | Hale David F | Purchase | 10,000 | 2.34 | 23,400 |
| 2008-04-16 | Credit Suisse/ (10% Owner) | Purchase | 196,633 | 2.34 | 460,121 |
| 2007-06-19 | Beck John W (Chief Financial Officer) | Sale | 3,400 | 8.05 | 27,376 |
| 2007-06-01 | Beck John W (Chief Financial Officer) | Sale | 10,035 | 8.00 | 80,330 |
| 2007-05-22 | Beck John W (Chief Financial Officer) | Sale | 300 | 8.00 | 2,400 |
| 2007-04-25 | Beck John W (Chief Financial Officer) | Sale | 3,300 | 8.13 | 26,829 |
| 2007-04-24 | Baracchini Edgardo Jr (Sr. VP of Business Development) | Sale | 4,300 | 8.21 | 35,303 |
| 2007-04-10 | Beck John W (Chief Financial Officer) | Sale | 6,172 | 8.00 | 49,376 |
| 2007-04-09 | Beck John W (Chief Financial Officer) | Sale | 1,828 | 8.00 | 14,624 |
| 2007-02-26 | Beck John W (Chief Financial Officer) | Sale | 3,300 | 8.00 | 26,400 |
| 2007-02-26 | Baracchini Edgardo Jr (Sr. VP of Business Development) | Sale | 700 | 8.00 | 5,600 |
| 2006-12-05 | Beck John W (Chief Financial Officer) | Sale | 9,000 | 8.00 | 72,000 |
| 2006-11-27 | Beck John W (CFO) | Sale | 500 | 8.01 | 4,005 |
| 2006-11-08 | Beck John W (Sr. VP, Finance & CFO) | Sale | 9,000 | 8.00 | 72,000 |
| 2006-11-03 | Credit Suisse/ (10% Owner) | Purchase | 527,000 | 7.17 | 3,776,323 |
| 2006-06-26 | Baracchini Edgardo Jr (Sr. VP, Business Development) | Sale | 500 | 8.35 | 4,175 |
| 2006-06-07 | Gschwend Heinz W (Director) | Option Exercise | 11,864 | 1.86 | 22,027 |
| 2006-05-22 | Cash Harvey B (10% Owner) | Purchase | 39,836 | 8.02 | 319,648 |
| 2006-05-19 | Cash Harvey B (10% Owner) | Purchase | 5,000 | 8.10 | 40,500 |
| 2006-05-18 | Cash Harvey B (10% Owner) | Purchase | 700 | 8.10 | 5,670 |
| 2006-05-16 | Cash Harvey B (10% Owner) | Purchase | 4,464 | 8.00 | 35,706 |
| 2006-03-01 | Beck John W (Chief Financial Officer) | Sale | 1,000 | 8.00 | 8,000 |
| 2005-09-30 | Rosch Thomas L (10% Owner) | Purchase | 426,621 | 5.86 | 2,499,999 |
| 2005-09-30 | Galakatos Nicholas (Director) | Purchase | 699,659 | 5.86 | 4,100,001 |
| 2005-09-30 | Oronsky Arnold L (Director) | Purchase | 426,621 | 5.86 | 2,499,999 |
| 2005-09-30 | Evnin Luke (10% Owner) | Purchase | 699,659 | 5.86 | 4,100,001 |
| 2005-09-30 | Credit Suisse First Boston/ (Other) | Purchase | 341,297 | 5.86 | 2,000,000 |
| 2005-09-07 | Gschwend Heinz W (Director) | Purchase | 5,000 | 4.18 | 20,900 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of METABASIS THERAPEUTICS INC (symbol MBRX,
CIK number 1053221) see
the Securities and Exchange Commission (SEC) website.
|
|
